1. Home
  2. GKOS vs WING Comparison

GKOS vs WING Comparison

Compare GKOS & WING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

N/A

Current Price

$103.96

Market Cap

6.9B

Sector

Health Care

ML Signal

N/A

Logo Wingstop Inc.

WING

Wingstop Inc.

N/A

Current Price

$211.31

Market Cap

6.7B

ML Signal

N/A

Company Overview

Basic Information
Metric
GKOS
WING
Founded
1998
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
6.9B
6.7B
IPO Year
2015
2015

Fundamental Metrics

Financial Performance
Metric
GKOS
WING
Price
$103.96
$211.31
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
14
28
Target Price
$133.07
$338.78
AVG Volume (30 Days)
662.2K
1.1M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
0.55%
EPS Growth
N/A
67.84
EPS
N/A
6.21
Revenue
$507,442,000.00
$696,853,000.00
Revenue This Year
$23.39
$18.23
Revenue Next Year
$27.46
$16.31
P/E Ratio
N/A
$35.41
Revenue Growth
32.33
11.35
52 Week Low
$73.16
$204.09
52 Week High
$130.23
$388.14

Technical Indicators

Market Signals
Indicator
GKOS
WING
Relative Strength Index (RSI) 35.28 35.54
Support Level $81.54 N/A
Resistance Level $106.52 $271.21
Average True Range (ATR) 3.58 12.90
MACD -1.81 -4.10
Stochastic Oscillator 14.28 2.58

Price Performance

Historical Comparison
GKOS
WING

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About WING Wingstop Inc.

Founded in 1994 in Garland, Texas, Wingstop is a restaurant operator specializing in indulgent bone-in and boneless chicken wings, chicken tenders, fries, and, recently, chicken sandwiches. The firm's footprint has grown quickly since its inception, expanding to 2,932 global stores at the end of the third quarter of 2025. With a 98% franchised model, Wingstop generates the lion's share of its revenue from franchise royalties and advertising fees, with the remainder derived from a small footprint of company-owned stores.

Share on Social Networks: